DrugPatentWatch Database Preview
Details for Patent: 8,796,276
Try a free trial
See Plans and Pricing
Which drugs does patent 8,796,276 protect, and when does it expire?
Patent 8,796,276 protects ARISTADA and ARISTADA INITIO KIT and is included in two NDAs.
This patent has thirty-eight patent family members in nineteen countries.
Summary for Patent: 8,796,276
| Title: | Heterocyclic compounds for the treatment of neurological and psychological disorders |
| Abstract: | Lactam compounds of Formula I and their use for the treatment of neurological and psychiatric disorders including schizophrenia, bipolar disorder, anxiety disorder and insomnia is disclosed. ##STR00001## |
| Inventor(s): | Remenar; Julius F. (Framingham, MA), Blumberg; Laura Cook (Lincoln, MA), Zeidan; Tarek A. (Watertown, MA) |
| Assignee: | Alkermes Pharma Ireland Limited (Dublin, IE) |
| Application Number: | 13/607,066 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,796,276
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alkermes Inc | ARISTADA | aripiprazole lauroxil | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207533-001 | Oct 5, 2015 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | TREATMENT OF SCHIZOPHRENIA | ➤ Sign Up | ||||
| Alkermes Inc | ARISTADA | aripiprazole lauroxil | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207533-002 | Oct 5, 2015 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | TREATMENT OF SCHIZOPHRENIA | ➤ Sign Up | ||||
| Alkermes Inc | ARISTADA | aripiprazole lauroxil | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207533-003 | Oct 5, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | TREATMENT OF SCHIZOPHRENIA | ➤ Sign Up | ||||
| Alkermes Inc | ARISTADA | aripiprazole lauroxil | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207533-004 | Jun 5, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | TREATMENT OF SCHIZOPHRENIA | ➤ Sign Up | ||||
| Alkermes Inc | ARISTADA INITIO KIT | aripiprazole lauroxil | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 209830-001 | Jun 29, 2018 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | TREATMENT OF SCHIZOPHRENIA | ➤ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,796,276
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 077239 | ➤ Sign Up | |||
| Argentina | 109699 | ➤ Sign Up | |||
| Australia | 2010266018 | ➤ Sign Up | |||
| Australia | 2010266040 | ➤ Sign Up | |||
| Canada | 2766033 | ➤ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
